Nephros, Inc. (NEPH)
NEPH Stock Price Chart
Explore Nephros, Inc. interactive price chart. Choose custom timeframes to analyze NEPH price movements and trends.
NEPH Company Profile
Discover essential business fundamentals and corporate details for Nephros, Inc. (NEPH) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
21 Sept 2004
Employees
31.00
Website
https://www.nephros.comCEO
Robert Banks
Description
Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells real-time water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it offers water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and AETHER brands for the food service, hospitality, convenience store, and health care markets. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
NEPH Financial Timeline
Browse a chronological timeline of Nephros, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$0.02, while revenue estimate is $3.87M.
Earnings released on 7 Aug 2025
EPS came in at $0.02 surpassing the estimated -$0.03 by +180.00%, while revenue for the quarter reached $4.42M , beating expectations by +22.72%.
Earnings released on 15 May 2025
EPS came in at $0.05 surpassing the estimated $0.01 by +400.00%, while revenue for the quarter reached $4.88M , beating expectations by +34.69%.
Earnings released on 24 Mar 2025
EPS came in at $0.03 surpassing the estimated -$0.01 by +400.00%, while revenue for the quarter reached $3.87M , beating expectations by +5.41%.
Earnings released on 7 Nov 2024
EPS came in at $0.02 surpassing the estimated $0.01 by +199.85%, while revenue for the quarter reached $3.52M , missing expectations by -1.46%.
Earnings released on 8 Aug 2024
EPS came in at -$0.03 falling short of the estimated -$0.02 by -100.00%, while revenue for the quarter reached $3.25M , missing expectations by -15.75%.
Earnings released on 9 May 2024
EPS came in at -$0.02 falling short of the estimated -$0.01 by -50.04%, while revenue for the quarter reached $3.52M , missing expectations by -5.58%.
Earnings released on 7 Mar 2024
EPS came in at -$0.06 falling short of the estimated -$0.03 by -140.00%, while revenue for the quarter reached $3.25M , missing expectations by -14.59%.
Earnings released on 8 Nov 2023
EPS came in at -$0.02 surpassing the estimated -$0.06 by +66.67%, while revenue for the quarter reached $3.74M , missing expectations by -1.78%.
Earnings released on 9 Aug 2023
EPS came in at -$0.04 surpassing the estimated -$0.05 by +20.00%, while revenue for the quarter reached $3.55M , beating expectations by +13.99%.
Earnings released on 10 May 2023
EPS came in at -$0.03 falling short of the estimated -$0.02 by -50.00%, while revenue for the quarter reached $3.70M , beating expectations by +0.46%.
Earnings released on 22 Feb 2023
EPS came in at -$0.10 falling short of the estimated -$0.06 by -66.67%, while revenue for the quarter reached $2.56M , missing expectations by -8.64%.
Earnings released on 2 Nov 2022
EPS came in at -$0.12 matching the estimated -$0.12, while revenue for the quarter reached $2.41M , missing expectations by -7.54%.
Earnings released on 10 Aug 2022
EPS came in at -$0.12 surpassing the estimated -$0.14 by +14.29%, while revenue for the quarter reached $2.88M , beating expectations by +8.79%.
Earnings released on 4 May 2022
EPS came in at -$0.20 falling short of the estimated -$0.13 by -53.85%, while revenue for the quarter reached $2.19M , missing expectations by -29.38%.
Earnings released on 23 Feb 2022
EPS came in at -$0.11 falling short of the estimated -$0.10 by -10.00%, while revenue for the quarter reached $2.77M , missing expectations by -2.93%.
Earnings released on 4 Nov 2021
EPS came in at -$0.12 matching the estimated -$0.12, while revenue for the quarter reached $2.64M , missing expectations by -10.00%.
Earnings released on 5 Aug 2021
EPS came in at -$0.12 matching the estimated -$0.12, while revenue for the quarter reached $2.27M , missing expectations by -4.79%.
Earnings released on 6 May 2021
EPS came in at -$0.06 surpassing the estimated -$0.14 by +57.14%, while revenue for the quarter reached $2.74M , missing expectations by -25.93%.
Earnings released on 1 Mar 2021
EPS came in at -$0.08 surpassing the estimated -$0.12 by +33.33%, while revenue for the quarter reached $2.33M .
Earnings released on 5 Nov 2020
EPS came in at -$0.12 surpassing the estimated -$0.16 by +25.00%, while revenue for the quarter reached $2.12M , missing expectations by -14.29%.
NEPH Stock Performance
Access detailed NEPH performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.